Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Knighty Tin who wrote (51675)	3/13/1999 12:40:00 AM
From: Merritt	Respond to of 132070

MB: <<< I think they are making progress in their goal to become THE transplant co. >>> And that's another thing that bothers me about SANG, going from a R&D biotech, to the operator of clinics. I'm always leery of a company that changes focus - too many chances to fail from maladministration. And another thing...what about the good work being done in xenotransplantation? It may only be two or three years before much of the GVHD is a thing of the past...check out BTRN, MEDI, Novartis, ALXN, and probably others (I haven't done a search, that's just off the top of my head.). I don't want to paint doom and gloom, but the fundamental picture has changed for them in the past six months-year. IMHO Best regards, Merritt